Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
JBJS Case Connect ; 13(3)2023 07 01.
Article in English | MEDLINE | ID: mdl-37708327

ABSTRACT

CASE: We present a male patient of low socioeconomic status and Maori ethnicity who experienced 3 episodes of presumed culture-negative septic arthritis of the native hip between ages 43 and 52 years. Each episode occurred within 3 weeks of intramuscular antipsychotic injection into the ipsilateral gluteal muscles. The right hip was involved in 2 presentations and the left hip in 1 presentation. No coexisting infection or underlying immune suppression was identified, and at follow-up 2 years after the last episode, he has no sequelae of septic arthritis. CONCLUSION: This report describes 3 episodes of presumed culture-negative septic arthritis after intramuscular antipsychotic injection.


Subject(s)
Antipsychotic Agents , Arthritis, Infectious , Humans , Male , Antipsychotic Agents/adverse effects , Arthritis, Infectious/drug therapy , Arthritis, Infectious/etiology , Disease Progression , Injections, Intramuscular/adverse effects , Maori People , Adult , Middle Aged
2.
Br J Hosp Med (Lond) ; 81(12): 1-6, 2020 Dec 02.
Article in English | MEDLINE | ID: mdl-33377837

ABSTRACT

There is an increasing trend towards dual surgeon operating in complex surgeries in various specialties. This is driven by regionalisation of services, increasing complexity of surgical procedures, the ageing population and challenges imposed by changes in surgical training. Dual surgeon cases have lower complication rates and better quality of patient care. This practice not only facilitates professional and personal development, but also provides valuable support to surgeons in the early part of their career. There is a paucity of literature to support this practice, however, and prospective studies are required to demonstrate the benefit of this approach.


Subject(s)
Orthopedic Procedures , Orthopedics , Reoperation , Surgeons , Arthroplasty , Humans , Orthopedics/organization & administration
3.
J Clin Orthop Trauma ; 11(Suppl 4): S534-S538, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32774025

ABSTRACT

BACKGROUND: Restoration of neutral mechanical axis is thought to influence implant survival and function in Total Knee Arthroplasty (TKA). There is no consensus whether Intramedullary (IM) or Extramedullary (EM) tibial alignment technique is superior to achieve this outcome. Study aims to evaluate functional and radiological outcome of TKA using the EM and IM technique. MATERIALS AND METHODS: A retrospective study of 400 primary TKA (314 patients) was performed. 200 knees were studied in each IM and EM group, which were matched. Functional assessment was performed using Oxford Knee Score (OKS) and Tibial component alignment measured in coronal and sagittal radiographs. RESULTS: The average coronal and sagittal alignment of the tibial component in IM group was 89.16° and 88°, whereas in EM group, these were 88.1° and 88.5° respectively. The adjusted mean difference change in Pre and Post-operative OKS in IM group compared to EM group was 0.5 (p = 0.52). There was no statistically significant difference in the complications between the two groups. Subgroup analysis of patients with BMI >35 showed predictable coronal tibial alignment with IM technique with fewer outliers. CONCLUSION: Intramedullary tibial alignment is associated with fewer outliers compared to the extramedullary technique particularly in patients with a BMI over 35.

4.
Eur J Orthop Surg Traumatol ; 30(2): 313-321, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31578679

ABSTRACT

INTRODUCTION: Prosthetic joint infection (PJI) remains one of the major challenges facing orthopaedic surgeons. There is a paucity of evidence on non-operative management of PJI. We present the results of prolonged antibiotic suppression therapy (PSAT) in PJI from a single centre. METHODS: A retrospective study was performed. Twenty-six patients were included. Two patients were excluded due to the lack of follow-up data. Failure was defined as admission for sepsis from the joint or amputation. RESULTS: Average age was 72 years (range 35-93). Mean Charlson co-morbidity index was 4.3. Mean follow-up was 3.2 years (range 1.3-5.7). Staphylococcal species were isolated in 11 cases (44%) (MRSA 1, MSSA 5, Staph. epidermidis 4 and Staph Pasteuri 1). Other bacteria included E. Coli (2), Streptococci spp. (3), Propionebacterium acnes (1) and Pseudomonas aeruginosa (1). Four cases were polymicrobial infection (16%), and no organisms were identified in two cases (8%). Candida albicans was identified in one case. All cases of bacterial infection were treated with prolonged oral doxycycline or amoxicillin. Twenty patients (80%) received 6 weeks of intravenous antibiotics prior to commencing prolonged oral antibiotics. Two patients experienced persistent symptoms and required amputation (both TKA). Two patients experienced sepsis but were treated successfully with IV antibiotics alone. The success rate of PSAT was 84% (21/25) successful at an average 3.2-year follow-up. DISCUSSION AND CONCLUSION: Prolonged suppressive antibiotic therapy is a viable option for the management of PJI with a low incidence of complications.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Joint Prosthesis/adverse effects , Prosthesis-Related Infections/drug therapy , Administration, Intravenous , Administration, Oral , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , Humans , Joint Prosthesis/microbiology , Middle Aged , Prosthesis-Related Infections/microbiology , Retrospective Studies , Sepsis/prevention & control
5.
Sci Rep ; 9(1): 18401, 2019 12 05.
Article in English | MEDLINE | ID: mdl-31804584

ABSTRACT

Heterotopic Ossification (HO) is a potential long-term complication in orthopaedic surgery. It is commonly classified according to the Brooker classification, which is based on radiological findings. To our knowledge the correlation of histological features to the Brooker grade is unknown as is the association between HO and the indication for revision. The aim of this paper is to analyze the ossification grade of HO tissue in patients undergoing revision hip and knee arthroplasty and to propose a histologically based classification system for HO. We also assess the relationship between the grade of HO and the indication for revision (septic and aseptic revision). From January to May 2019 we collected 50 human HO samples from hip and knee revision arthroplasty cases. These tissue samples were double-blinded and sent for histopathological diagnostic. Based on these results, we developed a classification system for the progression of HO. The grade of ossification was based on three characteristics: Grade of heterotopic ossification (Grade 1-3), presence of necrosis (N0 or N1) and the presence of osteomyelitis (HOES-Score Type 1 to 5). Demographic data as well as surgical details and indication for surgery was prospectively collected from clinical records. Fifty tissue samples were harvested from 44 hips and 6 knee joints. Of these 33 exhibited Grade I ossifications (66%), followed by 11 Grade II (22%) and one Grade III (2%). Necrosis was noted in two tissue samples (4%) and 2 more had osteomyelitis findings according to HOES-Score. Six samples (12%) with radiologically suggestive of HO turned out to be wear-induced synovitis, SLIM Type 1. Of these cases 16 were septic (32%) and 34 aseptic (68%) revisions. Most of the HO tissue samples were classified as a low-grade. High-grade ossification-Score is rare. Higher grades of ossification seem to be associated with septic revision cases. Wear-induced synovitis potentially influences HO development. A histological scoring system for ossification grading can be derived from the data presented in this study.


Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Knee/adverse effects , Necrosis/pathology , Ossification, Heterotopic/pathology , Osteomyelitis/pathology , Synovitis/pathology , Aged , Aged, 80 and over , Disease Progression , Female , Hip Joint/diagnostic imaging , Hip Joint/pathology , Hip Joint/surgery , Humans , Knee Joint/diagnostic imaging , Knee Joint/pathology , Knee Joint/surgery , Male , Middle Aged , Necrosis/diagnostic imaging , Necrosis/etiology , Necrosis/surgery , Ossification, Heterotopic/diagnostic imaging , Ossification, Heterotopic/surgery , Osteomyelitis/diagnostic imaging , Osteomyelitis/etiology , Osteomyelitis/surgery , Prospective Studies , Radiography , Severity of Illness Index , Synovitis/diagnostic imaging , Synovitis/etiology , Synovitis/surgery
6.
J Orthop Surg (Hong Kong) ; 27(1): 2309499019832752, 2019.
Article in English | MEDLINE | ID: mdl-30827174

ABSTRACT

BACKGROUND: Total knee arthroplasty (TKA) is an important option in the management of severe osteoarthritis. Despite excellent long-term results following TKA, the immediate postoperative period is often associated with pain, bleeding, edema, and reduced range of movement. Cryotherapy has been shown to provide some benefit in addressing these factors but results are largely controversial. This study aims at reviewing the current existing literature on the effects of cryotherapy following TKA. METHODS: A comprehensive review of the current literature on the use of cryotherapy in knee arthroplasty was performed. The literature search was performed using PubMed, Cochrane Library, Google Scholar, and cross references using the search words "cryotherapy" AND "knee arthroplasty" for articles published between January 1990 and November 2016. RESULTS: A total of 51 articles were analyzed and 24 of them were selected based on clinical relevance. CONCLUSION: Immediate and early postoperative management following TKA remains challenging. Cryotherapy has been shown to have some benefits but the severe lack of level 1 studies supporting its use make it difficult to reach a suitable conclusion. Further multicenter randomized controlled trials with representative populations and fair comparison of devices are needed.


Subject(s)
Arthroplasty, Replacement, Knee/adverse effects , Cryotherapy , Osteoarthritis, Knee/surgery , Pain, Postoperative/prevention & control , Postoperative Care , Humans , Pain, Postoperative/etiology
7.
Curr Rheumatol Rev ; 14(1): 46-52, 2018 Apr 20.
Article in English | MEDLINE | ID: mdl-27894239

ABSTRACT

BACKGROUND: Biologic agents have contributed significantly to the management of patients with in rheumatoid arthritis (RA). A significant proportion of patients with RA still require arthroplasty procedures however. It is unclear whether these agents increase the risk of post operative infection after lower limb arthroplasty. METHOD: A literature search was performed for articles published over the last 10 years in the English language examining the association between anti-tumour necrosis factor inhibitors and the incidence of post operative infection in patients with RA undergoing hip and knee arthroplasty procedures. RESULTS: One large meta-analysis has been published suggesting a 2-fold increase in infection rates following orthopaedic surgery in patients receiving biological agents. When subgroup analysis of arthroplasty cases alone was performed the finding failed to reach significance. However, several further studies have demonstrated both an increased risk for surgical site infection with the use of biological agents and several conflicting articles argue the opposite. CONCLUSION: There is no current consensus on this topic. The safety of continuation of perioperative anti-TNF-α therapy in patients undergoing lower limb arthroplasty procedures is unclear. There is also little robust guidance from specialist rheumatologic societies. There is need for large scale multicentre randomised controlled trials to address this issue.


Subject(s)
Antirheumatic Agents/adverse effects , Arthritis, Rheumatoid/drug therapy , Arthroplasty/adverse effects , Surgical Wound Infection/epidemiology , Biological Factors/adverse effects , Humans
8.
Bone Joint J ; 99-B(2): 199-203, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28148661

ABSTRACT

AIMS: We present the clinical and radiological results at a minimum follow-up of five years for patients who have undergone multiple cement-in-cement revisions of their femoral component at revision total hip arthroplasty (THA). PATIENTS AND METHODS: We reviewed the outcome on a consecutive series of 24 patients (10 men, 14 women) (51 procedures) who underwent more than one cement-in-cement revision of the same femoral component. The mean age of the patients was 67.5 years (36 to 92) at final follow-up. Function was assessed using the original Harris hip score (HHS), Oxford Hip Score (OHS) and the Merle D'Aubigné Postel score (MDP). RESULTS: The mean length of follow-up was 81.7 months (64 to 240). A total of 41 isolated acetabular revisions were performed in which stem removal facilitated access to the acetabulum, six revisions were conducted for loosening of both components and two were isolated stem revisions (each of these patients had undergone at least two revisions). There was significant improvement in the OHS (p = 0.041), HHS (p = 0.019) and MDP (p = 0.042) scores at final follow-up There were no stem revisions for aseptic loosening. Survival of the femoral component was 91.9% (95% confidence intervals (CI) 71.5 to 97.9) at five years and 91.7% (95% CI 70 to 97) at ten years (number at risk 13), with stem revision for all causes as the endpoint. CONCLUSION: Cement-in-cement revision is a viable technique for performing multiple revisions of the well cemented femoral component during revision total hip arthroplasty at a minimum of five years follow-up. Cite this article: Bone Joint J 2017;99-B:199-203.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Femur/surgery , Hip Joint/surgery , Adult , Aged , Aged, 80 and over , Arthroplasty, Replacement, Hip/adverse effects , Cementation , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prosthesis Failure , Reoperation , Retrospective Studies , Treatment Outcome
9.
Eur J Orthop Surg Traumatol ; 25(2): 217-20, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24811854

ABSTRACT

The average age of patients presenting for total joint arthroplasty is decreasing. The number of primary and revision arthroplasty procedures performed in the UK, Europe and USA is increasing annually. As number of procedures performed increases, the life expectancy of our patients and therefore the in vivo duration of prosthetic joints increase, and the potential for complications such as infection increases. One potential source for this is bacterial dissemination during dental surgery. Many attempts have been made to address this issue in the form of national guidelines, but there is no clear consensus on antibiotic prophylaxis before these procedures in order to decrease the risk of prosthetic joint infection. This continues to be an area of indecision and uncertainty resulting in patients having delays in their treatment while decisions are made by oral and orthopaedic surgeons about prophylactic antibiotic use. This article reviews the existing national guidelines, highlighting the current views and issues surrounding this subject, and a critical appraisal of current evidence for the use of prophylactic antibiotics in this patient population is presented. We will also review the response in literature to the 2009 American Academy of Orthopaedic Surgeons information statement release on antibiotic prophylaxis in joint arthroplasty patients undergoing dental procedures.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Oral Surgical Procedures/methods , Practice Guidelines as Topic , Prosthesis-Related Infections/prevention & control , Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , Australia , Hip Prosthesis/adverse effects , Humans , Knee Prosthesis/adverse effects , Oral Surgical Procedures/adverse effects , Prosthesis-Related Infections/etiology , United Kingdom , United States
11.
Eur J Orthop Surg Traumatol ; 24(7): 1211-5, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24402473

ABSTRACT

INTRODUCTION: Registries in both the United Kingdom and Sweden suggest that the popularity of uncemented femoral components is increasing. As this trend progresses, long-term survival data for such components are becoming increasingly more important. We present the results of a cohort of patients treated with the Omnifit (Stryker, Mahwah, NJ) femoral component with the follow-up of 10-15 years. METHODS: A prospective study was performed in our unit between 1996 and 2001. Patients were reviewed pre-operatively and then at 6, 12, 26 and 52 weeks post-operatively and annually thereafter. They were assessed clinically and radiographically, and the Merle d'Aubigne Postel (MDP) hip score was calculated at each visit. A visual analogue scale (VAS) score and satisfaction score were also recorded to assess patient satisfaction with their procedure. Specific enquiry was made regarding anterior thigh pain. Statistical calculations were performed using the Student's t test. Kaplan-Meier survival analysis was performed. RESULTS: One hundred and four patients (113 hips) were included (48 males, 56 females). Bilateral procedures were performed in nine patients. Mean age was 60.4 years (33-72 years). Mean follow-up was 12.9 years (10-15 years). Mean pre-operative MDP score was 8.8 (3-16) and VAS score 7.8 (1-10) with ten representing the most severe symptoms. At final follow-up, the average MDP and VAS scores were 16.9 (13-18) and 2.1 (0-6), respectively. High levels of satisfaction were reported by 96.1% of patients. Two dislocations and two cases of anterior thigh pain occurred. Four patients required revision surgery. Survival of the femoral component with revision for any reason as the end point was 96%. CONCLUSION: This prosthesis provides symptom relief, return to function and high levels of patient satisfaction in the long term. Survival of this component is comparable to the best results for primary total hip arthroplasty with any means of fixation.


Subject(s)
Arthroplasty, Replacement, Hip/instrumentation , Hip Joint , Hip Prosthesis , Musculoskeletal Pain/etiology , Patient Satisfaction , Adult , Aged , Arthroplasty, Replacement, Hip/adverse effects , Coated Materials, Biocompatible , Durapatite , Female , Follow-Up Studies , Hip Joint/diagnostic imaging , Hip Joint/physiopathology , Hip Prosthesis/adverse effects , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Prospective Studies , Radiography , Reoperation , Thigh , Titanium
12.
Acta Orthop Belg ; 80(3): 372-9, 2014 Sep.
Article in English | MEDLINE | ID: mdl-26280611

ABSTRACT

We present results of a prospective randomised controlled trial examining two cohorts of patients treated with proximally (Group A) and fully coated (Group B) femoral components with long term follow up. Patients were reviewed preoperatively and 6, 12, 26 and 52 weeks post operatively then annually. The Merle d'Aubigne Postel (MDP) hip score was used to assess clinical outcome. A Visual Analog Score (VAS) was also recorded. Statistical calculation was performed using the student's t- test and Kaplan Meier survival analysis. One hundred and four patients were included in group A and 103 patients in group B. Mean age was 60.4 years and 60.8 years respectively. Mean follow- up was 12.9 years. Mean pre-operative MDP scores were 8.8 and 9.5 in Groups A and B respectively. Mean pre-operative VAS score 7.8 and 7.4 respectively. At final follow up mean MDP and VAS were 16.9, 16.6 and 2.1, 2.4 respectively. Three femoral revisions occurred in Group A. Seven revisions occurred in Group B. Survival of the femoral component with revision for any reason as the end point was 96% in Group A and 94.8% in Group B. Both components produced symptomatic relief and similar revision rates. Thigh pain occurred only in Group A.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Femur/surgery , Hip Prosthesis , Hydroxyapatites , Osteoarthritis, Hip/surgery , Titanium , Adult , Aged , Arthritis, Rheumatoid/surgery , Arthroplasty, Replacement, Hip/instrumentation , Female , Femur Head Necrosis/surgery , Follow-Up Studies , Hip Dislocation/surgery , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Prosthesis Design , Prosthesis Failure , Reoperation , Treatment Outcome , Young Adult
13.
J Bone Joint Surg Br ; 92(10): 1370-5, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20884973

ABSTRACT

We prospectively evaluated the long-term outcome of 158 consecutive patients who underwent revision total hip replacement using uncemented computer-assisted design-computer-assisted manufacture femoral components. There were 97 men and 61 women. Their mean age was 63.1 years (34.6 to 85.9). The mean follow-up was 10.8 years (10 to 12). The mean Oxford, Harris and Western Ontario and McMaster hip scores improved from 41.1, 44.2 and 52.4 pre-operatively to 18.2, 89.3 and 12.3, respectively (p < 0.0001, for each). Six patients required further surgery. The overall survival of the femoral component was 97% (95% confidence interval 94.5 to 99.7). These results are comparable to those of previously published reports for revision total hip replacement using either cemented or uncemented components.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Computer-Aided Design , Hip Prosthesis , Prosthesis Design/methods , Adult , Age Distribution , Aged , Aged, 80 and over , Arthroplasty, Replacement, Hip/instrumentation , Cementation , Female , Follow-Up Studies , Hip Joint/diagnostic imaging , Humans , Male , Middle Aged , Prosthesis Failure , Radiography , Survival Analysis , Treatment Outcome
14.
Hip Int ; 18(4): 321-3, 2008.
Article in English | MEDLINE | ID: mdl-19097011

ABSTRACT

We describe the case of a patient who developed a notch on the femoral neck following a hip resurfacing operation as a result of a displaced acetabular component. The acetabular cup displaced in the coronal plane and impinged on the femoral neck leading to a large notch in the inferior femoral neck.


Subject(s)
Acetabulum/surgery , Arthroplasty, Replacement, Hip/adverse effects , Femur Neck/pathology , Hip Prosthesis/adverse effects , Osteolysis/etiology , Prosthesis Failure , Arthroplasty, Replacement, Hip/methods , Female , Femur Neck/diagnostic imaging , Femur Neck/surgery , Humans , Middle Aged , Osteolysis/diagnostic imaging , Osteolysis/surgery , Pain, Postoperative/etiology , Radiography , Reoperation
15.
Hip Int ; 18(3): 220-3, 2008.
Article in English | MEDLINE | ID: mdl-18924078

ABSTRACT

The number of hip resurfacing procedures performed in the United Kingdom has doubled in the last four years reflecting its popularity among orthopaedic surgeons. Of the available options the Birmingham Hip Resurfacing (BHR) prosthesis has been the most popular choice in this country. Despite this revision rates have been shown to be higher in the resurfacing group compared to the total hip arthroplasty group particularly in the early postoperative period. Revision of the BHR acetabular component is technically demanding due to several unique design features of this component. We discuss these features and describe a novel reliable and reproducible technique for revision of the BHR cup.


Subject(s)
Acetabulum/surgery , Arthroplasty, Replacement, Hip/instrumentation , Hip Joint/surgery , Hip Prosthesis , Postoperative Complications/prevention & control , Prosthesis Failure , Humans , Reoperation/adverse effects , Reoperation/methods
17.
Int J Surg ; 3(2): 141-6, 2005.
Article in English | MEDLINE | ID: mdl-17462275

ABSTRACT

INTRODUCTION: Since the pharmacological mode of action of botulinum toxin (BTX) has been elucidated, its therapeutic potential has been increasingly recognised. The aims of this review were to summarize our current understanding of the pharmacological action of this agent and to review its therapeutic uses. METHODS: An electronic literature search with Medline (January 1965 to December 2004) was carried out to identify articles related to the pharmacological mode of action and clinical uses for botulinum toxin using the keyword "botulinum toxin". RESULTS AND CONCLUSION: Botulinum toxin A is emerging as a valuable clinical tool, both for diagnostic and therapeutic purposes in a wide variety of disorders, and is already the treatment of choice for selected conditions. Better understanding of its modes of action may identify alternative targets for pharmacological intervention, and may allow development of longer acting drugs with lower immunogenicity. Therapeutic uses of BTX-A must be assessed systematically in prospective studies, and the clinical role of other subtypes requires evaluation.

SELECTION OF CITATIONS
SEARCH DETAIL